Over the past several decades, the analytical techniques pertaining to drug detection and characterization have evolved a great deal resulting in development, optimization and validation of vast array of methodologies and techniques. Continued efforts are being made for impurity profiling while bringing in better accuracy and precision for separation and quantification of the analytes. Pharmaceutica Analytica Acta reports these advances periodically. The current issue of the journal focuses on distribution of nasal spray droplet distribution, in silico studies on Spebrutinib and pharmaceutical analysis based on flow analysis techniques.
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When compared to other topical application of therapeutic agents, nasal spray is regarded as effective for rapid drug delivery and efficacy due to rich nasal vascularization and close proximity of olfactory region to the central nervous system. However, the droplet size distribution plays an important role in the safety of administration and its prevention from entering the tracheo-bronchi system. Rao et al. [1] have conducted analysis of nasal spray droplet size distribution and determined the effect of different actuation angle on the observations. The study revealed that velocity does not determine the droplet size though change in actuation angle did. The study emphasized that the method was precise, robust and has capacity to distinguish between different products. The developed method has immense relevance for evaluation of commercial nasal spray quality.
In silico studies are conducted in order to evaluate the efficacy of different drug analogues and their docking properties. Spebrutinib is a potential anti-cancerous agent as it effectively inhibits tyrosine kinase, an enzyme important for cancer cell survival. Al-Obaidi et al. [2] have conducted in silico studies using different analogues of this anti-cancerous agent. The design and docking studies were also useful for synthesis and chemical characterization of the analogues.
